In order to elucidate the connection between defective MMR and tumour resistance to 5-FU, numerous clinical studies have been done, particularly in colorectal cancer patients treated with 5-FU-based post operative adjuvant chemotherapies. The gene discussed is MRC1; the disease is colorectal cancer.